These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17708076)

  • 1. The P&T Committee's role in managing drugs for rare diseases.
    Tadlock C
    Manag Care Interface; 2007 Jun; 20(6):10, 13. PubMed ID: 17708076
    [No Abstract]   [Full Text] [Related]  

  • 2. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfying the P and T committee's need for more evidence.
    Cross M
    Manag Care; 2006 Oct; 15(10):22-4, 26-8, 31. PubMed ID: 17111693
    [No Abstract]   [Full Text] [Related]  

  • 5. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jumpstarting research into neglected diseases.
    Leslie M
    Cell; 2006 Nov; 127(3):443-5. PubMed ID: 17081963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in the anticipation of biosimilars: how must a P&T committee gear up?
    Tadlock C
    Manag Care Interface; 2007 Apr; 20(4):12, 14. PubMed ID: 17536251
    [No Abstract]   [Full Text] [Related]  

  • 9. Possibilities of applying the systems theory in the medical drug supply.
    Kiss GS
    Sante Publique (Bucur); 1978; 21(1-2):119-29. PubMed ID: 581801
    [No Abstract]   [Full Text] [Related]  

  • 10. European scheme to develop drugs for diseases with no treatment launched.
    Hawkes N
    BMJ; 2016 Mar; 352():i1385. PubMed ID: 26957004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of a therapeutics committee's work].
    Dolby J; Ekblom B; Elfvik P; Gunne LM; Jansson S; Kalling M; Nordlander NB; Skagerberg H; Anggård E
    Lakartidningen; 1974 Sep; 71(37):3355-6. PubMed ID: 4409501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs for neglected diseases: from pipeline to patients.
    Pécoul B
    PLoS Med; 2004 Oct; 1(1):e6. PubMed ID: 15526054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The concept of determining national requirements of essential drugs].
    Meshkovskiĭ AP
    Sov Zdravookhr; 1990; (11):62-5. PubMed ID: 2075502
    [No Abstract]   [Full Text] [Related]  

  • 15. Making medicines that children can take.
    Nunn AJ
    Arch Dis Child; 2003 May; 88(5):369-71. PubMed ID: 12716697
    [No Abstract]   [Full Text] [Related]  

  • 16. Laronidase opens door to treat other rare disorders.
    Morrow T
    Manag Care; 2004 Jun; 13(6):52-3. PubMed ID: 15259445
    [No Abstract]   [Full Text] [Related]  

  • 17. What makes an adverse drug reaction study valid?
    McEvilla JD
    Hospitals; 1967 Sep; 41(17):114-8. PubMed ID: 6065008
    [No Abstract]   [Full Text] [Related]  

  • 18. [International drug monitoring].
    Nir I
    Harefuah; 1973 Jan; 84(1):41-2. PubMed ID: 4692808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Organization of the German Pharmaceutical Councils and drug control in the so-called General Gouvernement 1939-1945].
    Jeśman C
    Arch Hist Med (Warsz); 1984; 47(3):403-15. PubMed ID: 6393904
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs and orphan diseases.
    Blin O; Micallef J
    Therapie; 2020 Apr; 75(2):131-132. PubMed ID: 32247679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.